Zobrazeno 41 - 50
of 217
pro vyhledávání: '"Zhi-Qiang Xiao"'
Autor:
Yaoyun Tang, Zhi-Qiang Xiao, Qi-Guang Li, Shan-Shan Lu, Zheng-Zheng Yu, Wei Huang, Xiao-Pu Huang, Hong Yi, Ta Xiao, Wei Zhu
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 5, Pp 1-13 (2020)
Cell Death and Disease, Vol 11, Iss 5, Pp 1-13 (2020)
HDAC7 plays a crucial role in cancers, and is the main drug target of several HDAC inhibitors. However, the role and mechanism of HDAC7 in nasopharyngeal carcinoma (NPC) are still unclear. In this study, we observed that HDAC7 was significantly upreg
Autor:
Zheng-Zheng Yu, Song-Qing Fan, Wei Zhu, Hong Yi, Xueping Feng, Ta Xiao, Juan Feng, Wei Huang, Shan-Shan Lu, Jiao-Yang Li, Guo-Hui Nie, Zhi-Qiang Xiao, Song Gao, Yaoyun Tang
Publikováno v:
Cancer research. 80(20)
Overexpression of ANXA1 and EphA2 has been linked to various cancers and both proteins have attracted considerable attention for the development of new anticancer drugs. Here we report that ANXA1 competes with Cbl for binding EphA2 and increases its
Autor:
Wei Huang, Hong Yi, Xiao‑Pu Hung, Zhi‑Qiang Xiao, Shan‑Shan Lu, Yao‑Yun Tang, Juan Feng, Qiu‑Yan He, Ta Xiao
Publikováno v:
International journal of oncology. 57(5)
EphA2 (EPH receptor A2) (erythropoietin‑producing hepatocellular receptor tyrosine kinase subtype A2) plays a crucial role in human cancers, and is a promising target for the development of new anticancer drugs. In this study, we showed that the in
MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
Autor:
Li-Na Li, Zhen Zheng, Shan-Shan Lu, Xu Ye, Jia-Quan Qu, Ta Xiao, Wei Huang, Hong-Mei Yi, Xin-Hui Li, Zhi-Qiang Xiao, Hong Yi
Publikováno v:
Molecular Cancer Therapeutics. 16:2094-2106
Radioresistance poses a major challenge in nasopharyngeal carcinoma (NPC) treatment, but little is known about how miRNA regulates this phenomenon. In this study, we investigated the function and mechanism of miR-125b in NPC radioresistance, one of u
Autor:
Xiao‑Pu Hung, Wei Huang, Yao‑Yun Tang, Juan Feng, Shan‑Shan Lu, Zhi‑Qiang Xiao, Qiu‑Yan He, Ta Xiao, Hong Yi
Publikováno v:
International Journal of Oncology. 58:133-134
Following the publication of the above article, the authors have realized that one of the data panels featured in Fig. 5D was selected incorrectly. Specifically, the wrong image was selected for the A1 (28‑30), HCT116 experiment. The authors have r
Autor:
Facai Cui, Zhi-Qiang Xiao, Kun Wang, Bin Yi, Ya Tao, Shiyang Qiu, Lepan Zhu, Manlin Xiang, Yunlai Liang, Lu Long, Yuan Jiang, Qiong Wu, Zhen Chen
Publikováno v:
Oncotarget
// Ya Tao 1,* , Kun Wang 1,* , Zhen Chen 1 , Lu Long 1 , Qiong Wu 1 , Facai Cui 1 , Lepan Zhu 1 , Manlin Xiang 1 , Yuan Jiang 1,2 , Yunlai Liang 1 , Shiyang Qiu 1 , Zhiqiang Xiao 3 and Bin Yi 1 1 Department of Clinical Laboratory, Xiangya Hospital, C
Autor:
Zheng-Zheng Yu, Shan-Shan Lu, Wei Zhu, Wei Huang, Guo-Hui Nie, Zhi-Qiang Xiao, Yaoyun Tang, Xueping Feng, Juan Feng, Jiao-Yang Li, Ta Xiao, Hong Yi, Song Gao, Song-Qing Fan
Publikováno v:
SSRN Electronic Journal.
ANXA1 and EphA2 play a crucial role in cancer. Here, we report that ANXA1 competes with Cbl for binding EphA2 and increases its stability by inhibiting Cbl-mediated EphA2 ubiquitination degradation in nasopharyngeal carcinoma (NPC), leading to the en
Autor:
Li-Na Li, Ta Xiao, Hong-Mei Yi, Zhen Zheng, Jia-Quan Qu, Wei Huang, Xu Ye, Hong Yi, Shan-Shan Lu, Xin-Hui Li, Zhi-Qiang Xiao
Publikováno v:
Molecular cancer therapeutics. 17(11)
Autor:
Wei Huang, Zhi-Qiang Xiao, David Wei Zhang, Hong-Liang Lu, Xiao-Xi Li, Te-Kuang Chiang, Wei Wang, Zhigang Ji
Publikováno v:
Superlattices and Microstructures. 150:106744
A novel combined GaN/Si device based on compatible CMOS semiconductor, merged heterojunction barrier Schottky (MHBS) diode is put forward and its generalized analytical heterojunction model is further built and validated. The fully two-dimension (2D)
Autor:
Lu Long, Zhi-Qiang Xiao, Shiyang Qiu, Lepan Zhu, Yunlai Liang, Bin Yi, Ya Tao, Qiong Wu, Manlin Xiang, Zhen Chen, Kun Wang, Facai Cui
Publikováno v:
Oncotarget
// Zhen Chen 1,* , Lu Long 1,* , Kun Wang 1 , Facai Cui 1 , Lepan Zhu 1 , Ya Tao 1 , Qiong Wu 1 , Manlin Xiang 1 , Yunlai Liang 1 , Shiyang Qiu 1 , Zhiqiang Xiao 2 and Bin Yi 1 1 Department of Clinical Laboratory, Xiangya Hospital, Central South Univ